Brief: Hls Therapeutics Announces Updates To Its Credit Agreement
14/08/2023 12:07
HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS ANNOUNCES UPDATES TO ITS CREDIT AGREEMENT
* HLS THERAPEUTICS INC: EXTENSION TO ITS CREDIT AGREEMENT,
SENIOR
SECURED TERM LOAN, REVOLVER FACILITY AND EXPANSION FACILITY
* HLS THERAPEUTICS INC: UNDER TERMS OF AMENDED AGREEMENT,
MATURITY
DATE HAS BEEN EXTENDED TO AUGUST 11, 2026
* HLS THERAPEUTICS INC: THERE IS A NEW REVOLVING FACILITY OF
$30.0
MILLION AND AN EXPANSION FACILITY OF UP TO $70.0 MILLION AS PART
OF AMENDMENT
Source text for Eikon: ID:nCNW94LmFa
Further company coverage: HLS.TO
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease